Last updated on May 30th, 2021
Superantigens are microbial peptides that can polyclonally activate a large fraction of T cells (up to 20%). They escape normal antigen processing by antigen presenting cells (APCs) and can directly bind to T cell receptor (TCR).
This binding of TCR with MHC-II by superantigen results into polyclonal activation of T cells which can ultimately result in life-threatening autoimmune responses, even deaths.
Superantigens bind simultaneously to the Vβ domain of a T-cell receptor and to the α chain of a class II MHC molecule. Crosslinkage of a T-cell receptor and class II MHC molecule produces an activating signal that induces T-cell activation and proliferation. The number of T cells sharing
Superantigens polyclonally activate a large fraction (up to 25%) of the T cells, setting off massive immune response whereas in T dependent antigen only a fraction of (1 in 10^6 -10^4) of the T cell population is able to recognize the antigen and become activated. The massive activation of T cells results in overproduction of TH cell cytokines (TNF alpha, IL-1, IL-6) leading to systemic toxicity, multi-organ failure and even death in some cases.
Both exogenous and endogenous superantigens have been identified. Exogenous superantigens are soluble proteins secreted by bacteria e.g. Staphylococcus aureus (TSST-1) and Streptococcus
Examples of Bacterial Superantigens and their roles:
- Staphylococcal enterotoxins: Food poisoning
- Staphylococcal toxic shock toxin (TSST-1): Toxic shock syndrome
- Staphylococcal exfoliating toxins: Scalded skin syndrome
- Streptococcal pyrogenic exotoxins (exotoxin A and exotoxin B): Shock
Conventional antigen Vs. Superantigen
Some of the key features of conventional antigen and superantigen is summarized in the table below:
Difference between conventional antigen and superantigen
|Nature||Antigens are foreign substances (mostly proteins, polysaccharide) or altered self proteins that induces specific immune response.||Superantigens are microbial peptides that can polyclonally activate large portion of T cells.|
|Antigen Processing and Presentation||Conventional protein antigens are processed by B cell and a peptide of the protein antigen is presented to its matching antigen-specific CD4 T cell via MHC-II-peptide||Superantigens are not processed intracellularly, instead, they bind class II MHC molecules as intact macromolecules and bind outside of the peptide-antigen binding groove.|
|Binding with T cells||Classical antigens bind to the highly variable peptide groove of the T-cell receptor.||Superantigen binds/interact with the more conserved Vβ region of T cell receptor. All T cells that express that particular Vβ region are subject to activation regardless of antigen specificity.|
|Need of costimulatory signal||Successful T cell activation by conventional antigen requires multiple signals. Presentation of MHC-II-peptide-TCR is not enough to stimulate T cells. It requires co-stimulatory signal provided by an interaction between members of the B7 family (either CD80 or CD86) on APCs and CD28 on T cells.||Superantigens can activate T lymphocytes in the absence of costimulatory molecules.|
|T Cell Activation||Conventional peptide antigens generally activate only the small fraction of the T cell population (i.e. <0.01% T Cells).||Superantigens (SAgs) have the ability to stimulate 2-30% of the T cell repertoire.|